Learn More
Invitrogen™ Eotaxin 3 Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547851
Description
In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) Eotaxin, recombinant mouse (rm) Eotaxin, rhEotaxin-2, and rmEotaxin-2 is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
Eotaxin-3 is a small cytokine belonging to the CC chemokine family that is also called CCL26, Chemokine (C-C motif) ligand 26. Chemokines play pivotal roles in health and disease by controlling migration and tissue localization of specific types of cells expressing their cognate receptors. Eotaxin-3 is chemotactic for eosinophils and basophils and elicits its effects by binding to the cell surface chemokine receptor CCR3. It is expressed by several tissues including heart, lung and ovary, and in endothelial cells that have been stimulated with the cytokine interleukin 4. This gene for chemokine is located on human chromosome 7. Eotaxin-3 induced migration of eosinophils and basophils only at a 10-fold higher concentration than eotaxin.
Specifications
| Eotaxin 3 | |
| Polyclonal | |
| Unconjugated | |
| CCL26 | |
| CC chemokine IMAC; C-C motif chemokine 26; C-C motif chemokine ligand 26; Ccl26; Ccl26l; chemokine (C-C motif) ligand 26; chemokine N1; Eotaxin3; eotaxin-3; IMAC; Macrophage inflammatory protein 4-alpha; MGC126714; MIP-4a; MIP-4alpha; MIP-4-alpha; PRO242; SCYA26; SCYA26MIP-4-alpha; small inducible cytokine A26; small inducible cytokine subfamily A (Cys-Cys), member 26; small-inducible cytokine A26; Thymic stroma chemokine-1; TSC-1; UNQ216; UNQ216/PRO242 | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 10344 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
| Immunohistochemistry, Immunohistochemistry (Paraffin), Neutralization, Western Blot | |
| 0.2 mg/mL | |
| PBS with 5% trehalose and No Preservative | |
| Q9Y258 | |
| CCL26 | |
| E. coli-derived recombinant human CCL26/Eotaxin-3 Thr24-Leu94. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
Your input is important to us. Please complete this form to provide feedback related to the content on this product.